Literature DB >> 10991734

Microbiology. How to get along--friendly microbes in a hostile world.

R J Xavier1, D K Podolsky.   

Abstract

Microbiologists have long been puzzled by the finding that the gut mucosa does not respond to the myriad varieties of bacteria that normally reside in the gut. As Xavier and Podolsky explain in their Perspective, this may be because bacteria that are indigenous to the gut have learned ways to switch off pathways in gut epithelial cells that lead to switching on of genes involved in inflammation (Neish et al.).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10991734     DOI: 10.1126/science.289.5484.1483

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  11 in total

1.  Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium.

Authors:  Elke Cario; Dennis Brown; Mary McKee; Kathryn Lynch-Devaney; Guido Gerken; Daniel K Podolsky
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 2.  Probiotics in the management and prevention of atopy.

Authors:  John Bienenstock; Ryan E Wiley; G Scott Neigh; Susan Waserman; Paul Keith
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

3.  Modeling the interactions of bacteria and Toll-like receptor-mediated inflammation in necrotizing enterocolitis.

Authors:  Julia Arciero; G Bard Ermentrout; Richard Siggers; Amin Afrazi; David Hackam; Yoram Vodovotz; Jonathan Rubin
Journal:  J Theor Biol       Date:  2012-12-10       Impact factor: 2.691

4.  Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models.

Authors:  K A Eaton; D Kersulyte; M Mefford; S J Danon; S Krakowka; D E Berg
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection.

Authors:  B Schmausser; M Andrulis; S Endrich; S K Lee; C Josenhans; H-K Müller-Hermelink; M Eck
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 6.  Enteric alpha defensins in norm and pathology.

Authors:  Nikolai A Lisitsyn; Yulia A Bukurova; Inna G Nikitina; George S Krasnov; Yuri Sykulev; Sergey F Beresten
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-01-11       Impact factor: 3.944

7.  Recombinant human trefoil factor 3 ameliorates bowel injury: its anti-inflammatory effect on experimental necrotizing enterocolitis.

Authors:  Lei Shi; Pang-Hu Zhou; Juan-Li Xi; Hong-Gang Yu; Bing-Hong Zhang
Journal:  Int J Pept       Date:  2014-02-12

8.  Expression of Toll-like receptors in the mucosa of patients with ulcerative colitis.

Authors:  Yujing Fan; Bingrong Liu
Journal:  Exp Ther Med       Date:  2015-02-04       Impact factor: 2.447

9.  Effects of reduced glutathione therapy on chronic hepatitis B.

Authors:  Li Qian; Wenjun Wang; Yan Zhou; Jianxin Ma
Journal:  Cent Eur J Immunol       Date:  2017-05-08       Impact factor: 2.085

Review 10.  Bacterial interference with canonical NFκB signalling.

Authors:  Mona Johannessen; Fatemeh Askarian; Maria Sangvik; Johanna E Sollid
Journal:  Microbiology       Date:  2013-07-19       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.